Patents by Inventor Philippe DELAY-GOYET

Philippe DELAY-GOYET has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • H3 receptor antagonist for use in the treatment of alzheimer's disease
    Patent number: 9789102
    Abstract: This disclosure relates to methods of using 2-(cyclohexylmethyl)-N-{2-[(2S)-1-methylpyrrolidin-2-yl]ethyl}-1,2,3,4-tetrahydroisoquinoline-7-sulfonamide in a disease modifying therapy of Alzheimer's disease, other tauopathies and related neurodegenerative diseases.
    Type: Grant
    Filed: October 1, 2015
    Date of Patent: October 17, 2017
    Assignee: SANOFI
    Inventors: Pascal Barneoud, Veronique Blanchard-Bregeon, Veronique Mary, Jean Menager, Philippe Delay-Goyet, Mathilde Lopez-Grancha, Thomas Rooney, Nathalie Schussler
  • H3 RECEPTOR ANTAGONIST FOR USE IN THE TREATMENT OF ALZHEIMER'S DISEASE
    Publication number: 20160256449
    Abstract: The disclosure relates to the compound 2-(cyclohexylmethyl)-N-{2-[(2S)-1-methylpyrrolidin-2-yl]ethyl}-1,2,3,4-tetrahydroisoquinoline-7-sulfonamide or a pharmaceutically acceptable salt thereof, intended for the treatment of Alzheimer's disease and other types of dementia.
    Type: Application
    Filed: March 8, 2016
    Publication date: September 8, 2016
    Inventors: Sophie CLAUDEL, Jeanne STEMMELIN, Pascal BARNEOUD, Philippe DELAY-GOYET, Mathilde LOPEZ-GRANCHA, Jeremy PRATT
  • Use of 4-cyclopropylmethoxy--(3,5-dichloro-1-oxido-4-pyridin-4-yl)-5-(methoxy)pyridine-2-carboxamide in the treatment of cranial traumas
    Patent number: 9393236
    Abstract: The invention relates to the use of 4-cyclopropylmethoxy-N-(3,5-dichloro-1-oxidopyridin-4-yl)-5-(methoxy)pyridine-2-carboxamide for the preparation of a medicament for use in the treatment of cerebral traumas.
    Type: Grant
    Filed: October 5, 2009
    Date of Patent: July 19, 2016
    Assignee: SANOFI
    Inventors: Philippe Delay-Goyet, Corinne Perron
  • H3 RECEPTOR ANTAGONIST FOR USE IN THE TREATMENT OF ALZHEIMER'S DISEASE
    Publication number: 20160101099
    Abstract: This disclosure relates to methods of using 2-(cyclohexylmethyl)-N-{2-[(2S)-1-methylpyrrolidin-2-yl]ethyl}-1,2,3,4-tetrahydroisoquinoline-7-sulfonamide in a disease modifying therapy of Alzheimer's disease, other tauopathies and related neurodegenerative diseases.
    Type: Application
    Filed: October 1, 2015
    Publication date: April 14, 2016
    Inventors: Pascal BARNEOUD, Veronique BLANCHARD-BREGEON, Veronique MARY, Jean MENAGER, Philippe DELAY-GOYET, Mathilde LOPEZ-GRANCHA, Thomas ROONEY, Nathalie SCHUSSLER
  • AN H3 RECEPTOR ANTAGONIST FOR USE IN THE TREATMENT OF ALZHEIMER'S DISEASE
    Publication number: 20150031893
    Abstract: This disclosure relates to methods of using 2-(cyclohexylmethyl)-N-{2-[(2S)-1-methylpyrrolidin-2-yl]ethyl}-1,2,3,4-tetrahydroisoquinoline-7-sulfonamide in a disease modifying therapy of Alzheimer's disease, other tauopathies and related neurodegenerative diseases.
    Type: Application
    Filed: October 3, 2014
    Publication date: January 29, 2015
    Inventors: Pascal BARNEOUD, Veronique BLANCHARD-BREGEON, Veronique MARY, Jean MENAGER, Philippe DELAY-GOYET, Mathilde LOPEZ GRANCHA, Thomas ROONEY, Nathalie SCHUSSLER
  • Use of 4 cyclopropylmethoxy--(3,5 dichloro-1 oxido-pyridin-4 yl)-5-(methoxy)pyridine-2-carboxamide for the treatment of spinal cord traumas
    Patent number: 8592443
    Abstract: The present invention relates to the use of 4-cyclopropylmethoxy-N-(3,5-dichloro-1-oxidopyridin-4-yl)-5-(methoxy)pyridine-2-carboxamide, in the form of a hydrate, of a solvate, of a base or of an addition salt with an acid, for the preparation of a medicament for use in the treatment of spinal cord traumas.
    Type: Grant
    Filed: October 5, 2009
    Date of Patent: November 26, 2013
    Assignee: Sanofi
    Inventors: Philippe Delay-Goyet, Badia Ferzaz, Jocelyne Lolivier
  • USE OF 4 CYCLOPROPYLMETHOXY-N-(3,5 DICHLORO-1 OXIDO-PYRIDIN-4 YL)-5-(METHOXY)PYRIDINE-2 CARBOXAMIDE FOR THE TREATMENT OF SPINAL CORD TRAUMAS
    Publication number: 20100137370
    Abstract: The present invention relates to the use of 4-cyclopropylmethoxy-N-(3,5-dichloro-1-oxidopyridin-4-yl)-5-(methoxy)pyridine-2-carboxamide, in the form of a hydrate, of a solvate, of a base or of an addition salt with an acid, for the preparation of a medicament for use in the treatment of spinal cord traumas.
    Type: Application
    Filed: October 5, 2009
    Publication date: June 3, 2010
    Applicant: SANOFI-AVENTIS
    Inventors: Philippe DELAY-GOYET, Badia FERZAZ, Jocelyne LOLIVIER
  • USE OF 4-CYCLOPROPYLMETHOXY-N-(3,5-DICHLORO-1-OXIDOPYRIDIN-4-YL)-5-(METHOXY)PYRIDINE-2-CARBOXAMIDE FOR THE TREATMENT OF MOTOR DISORDERS RELATED TO PARKINSON'S DISEASE
    Publication number: 20100130554
    Abstract: The present invention relates to the use of 4-cyclopropylmethoxy-N-(3,5-dichloro-1-oxidopyridin-4-yl)-5-(methoxy)pyridine-2-carboxamide in the form of a hydrate, of a solvate, of a base or of an addition salt with an acid, for preparing a medicament for use in the treatment of motor disorders related to Parkinson's disease.
    Type: Application
    Filed: October 5, 2009
    Publication date: May 27, 2010
    Applicant: SANOFI-AVENTIS
    Inventors: Philippe DELAY-GOYET, Claire DELGORGE, Christine MENET, Gilles POUGHON, Christine RAVINET-TRILLOU
  • USE OF 4-CYCLOPROPYLMETHOXY-N-(3,5-DICHLORO-1-OXIDO-4-PYRIDIN-4-YL)-5-(METHOXY)PYRIDINE-2-CARBOXAMIDE IN THE TREATMENT OF CRANIAL TRAUMAS
    Publication number: 20100130553
    Abstract: The invention relates to the use of 4-cyclopropylmethoxy-N-(3,5-dichloro-1-oxidopyridin-4-yl)-5-(methoxy)pyridine-2-carboxamide for the preparation of a medicament for use in the treatment of cerebral traumas.
    Type: Application
    Filed: October 5, 2009
    Publication date: May 27, 2010
    Applicant: SANOFI-AVENTIS
    Inventors: Philippe DELAY-GOYET, Corinne PERRON